1
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hamashima C: Current issues and future
perspectives of gastric cancer screening. World J Gastroenterol.
20:13767–13774. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Tong XH, Xu B, Zhang YW, Liu YS and Ma CH:
Research resources: Comparative microRNA profiles in human corona
radiata cells and cumulus oophorus cells detected by
next-generation small RNA sequencing. PLoS One. 9:e1067062014.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Aghanoori MR, Mirzaei B and Tavallaei M:
MiRNA molecular profiles in human medical conditions: Connecting
lung cancer and lung development phenomena. Asian Pac J Cancer
Prev. 15:9557–9565. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hua HB, Yan TT and Sun QM: miRNA
polymorphisms and risk of gastric cancer in Asian population. World
J Gastroenterol. 20:5700–5707. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang HB, Jiang ZB and Li M: Research on
the typical miRNA and target genes in squamous cell carcinoma and
adenocarcinoma of esophagus cancer with DNA microarray. Pathol
Oncol Res. 20:245–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gailhouste L, Gomez-Santos L and Ochiya T:
Potential applications of miRNAs as diagnostic and prognostic
markers in liver cancer. Front Biosci (Landmark Ed). 18:199–223.
2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tölle A, Ratert N and Jung K: miRNA panels
as biomarkers for bladder cancer. Biomark Med. 8:733–746. 2014.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Rajaram K, Harding RL, Bailey T, Patton JG
and Hyde DR: Dynamic miRNA expression patterns during retinal
regeneration in zebrafish: Reduced dicer or miRNA expression
suppresses proliferation of Müller glia-derived neuronal progenitor
cells. Dev Dyn. 243:1591–1605. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhang Y, Ma Y, Xu W, Li W, Min P, Qiu J,
Li M, Tang F, Zhang M, Yang D and Zhang J: Association of
microRNA-933 variant with the susceptibility to gastric cancer. J
BUON. 22:390–395. 2017.PubMed/NCBI
|
11
|
Yan H, Wang S, Yu H, Zhu J and Chen C:
Molecular pathways and functional analysis of miRNA expression
associated with paclitaxel-induced apoptosis in hepatocellular
carcinoma cells. Pharmacology. 92:167–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol. 15:4292014.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Ooms LM, Binge LC, Davies EM, Rahman P,
Conway JR, Gurung R, Ferguson DT, Papa A, Fedele CG, Vieusseux JL,
et al: The inositol polyphosphate 5-Phosphatase PIPP regulates
AKT1-Dependent breast cancer growth and metastasis. Cancer Cell.
28:155–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sahlberg SH, Spiegelberg D, Glimelius B,
Stenerlöw B and Nestor M: Evaluation of cancer stem cell markers
CD133, CD44, CD24: Association with AKT isoforms and radiation
resistance in colon cancer cells. PLoS One. 9:e946212014.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Etemadmoghadam D and Bowtell D: AKT1 gene
amplification as a biomarker of treatment response in ovarian
cancer: Mounting evidence of a therapeutic target. Gynecol Oncol.
135:409–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Summers SA and Birnbaum MJ: A role for the
serine/threonine kinase, Akt, in insulin-stimulated glucose uptake.
Biochem Soc Trans. 25:981–988. 1997. View Article : Google Scholar : PubMed/NCBI
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Hummel R, Sie C, Watson DI, Wang T, Ansar
A, Michael MZ, Van der Hoek M, Haier J and Hussey DJ: MicroRNA
signatures in chemotherapy resistant esophageal cancer cell lines.
World J Gastroenterol. 20:14904–14912. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Xu X, Chen R, Li Z, Huang N, Wu X, Li S,
Li Y and Wu S: MicroRNA-490-3p inhibits colorectal cancer
metastasis by targeting TGFβR1. Bmc Cancer. 15:10232015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chen S, Chen X, Xiu YL, Sun KX and Zhao Y:
MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial
carcinoma tumorigenesis and progression. Cancer Lett. 362:122–130.
2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang LL, Sun KX, Wu DD, Xiu YL, Chen X,
Chen S, Zong ZH, Sang XB, Liu Y and Zhao Y: DLEU1 contributes to
ovarian carcinoma tumourigenesis and development by interacting
with miR-490-3p and altering CDK1 expression. J Cell Mol Med.
21:3055–3065. 2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Liu W, Xu G, Liu H and Li T:
MicroRNA-490-3p regulates cell proliferation and apoptosis by
targeting HMGA2 in osteosarcoma. FEBS Lett. 589:3148–3153. 2015.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Sasaki T and Kuniyasu H: Significance of
AKT in gastric cancer (Review). Int J Oncol. 45:2187–2192. 2014.
View Article : Google Scholar : PubMed/NCBI
|
24
|
He J, Zhu G, Gao L, Chen P, Long Y, Liao
S, Yi H, Yi W, Pei Z, Wu M, et al: Fra-1 is upregulated in gastric
cancer tissues and affects the PI3K/Akt and p53 signaling pathway
in gastric cancer. Int J Oncol. 47:1725–1734. 2015. View Article : Google Scholar : PubMed/NCBI
|